Shingles vaccine linked to 24% lower dementia risk in major US study

GB News 26 Aug United Kingdom

The Shingrix shingles vaccine is associated with a 24 per cent reduction in dementia risk among older adults, providing further evidence that immunisation may serve as a shield for the brain, according to a new study from Brown University. Research published yesterday in the Annals of Internal Medicine examined more than half a million individuals residing in skilled nursing facilities across the

Aggregated from the leading newsrooms of the country. Every story links to its original source.